Highlights and Quick Summary
- Net Debt/EBITDA for the quarter ending December 31, 2022 was 1.77 (a -49.11% decrease compared to previous quarter)
- Year-over-year quarterly Net Debt/EBITDA decreased by -22.27%
- Annual Net Debt/EBITDA for 2022 was 0.2 (a 6.31% increase from previous year)
- Annual Net Debt/EBITDA for 2022 was 0.19 (a -87.37% decrease from previous year)
- Annual Net Debt/EBITDA for 2021 was 1.48 (a -0.3% decrease from previous year)
Visit stockrow.com/BNTC
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Net Debt/EBITDA of Benitec Biopharma Limited
Most recent Net Debt/EBITDAof BNTC including historical data for past 10 years.Interactive Chart of Net Debt/EBITDA of Benitec Biopharma Limited
Benitec Biopharma Limited Net Debt/EBITDA for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | 1.77 | 3.48 | 0.69 | 2.28 | 0.2 |
| 2021 | 2.39 | 3.1 | 5.15 | 3.15 | 1.48 |
| 2020 | 4.29 | 2.68 | 3.36 | 5.31 | 1.19 |
| 2019 | – | – | 6.37 | 0.0 | -5.73 |
| 2018 | – | – | – | – | 1.42 |
| 2017 | – | – | – | 5.24 | 3.21 |
| 2016 | – | -13.53 | 0.0 | 0.0 | 0.86 |
| 2015 | – | – | 0.0 | 0.0 | 2.11 |
| 2014 | – | – | 0.0 | 0.0 | 4.26 |
| 2013 | 0.0 | – | – | – | 0.46 |
Business Profile of Benitec Biopharma Limited
Sector: Healthcare
Industry: Biotechnology